Astrazeneca News - AZN

Best deals to access real time data!
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
London Stock Exchange Level 2
Monthly Subscription
for only
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Astrazeneca Plc AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -41.00 -0.52% 7,837.00 7,946.00 7,821.00 7,906.00 7,878.00 11:35:07
more quote information »
Industry Sector

Recent News

Date Time Source Heading
1/20/202003:33ALNCUS Grants AstraZeneca's Lynparza Priority Review For..
1/20/202002:48DJNAstraZeneca: FDA Gives Orphan Drug Status to Two Liver..
1/20/202002:46DJNAstraZeneca's Prostate Cancer Supplemental Drug Gets U.S...
1/20/202002:00UKREGAstraZeneca PLC Imfinzi, tremelimumab granted ODD in liver..
1/14/202012:03DJNMy Green Lab Working with AstraZeneca to Implement Green..
1/13/202008:22DJNAstraZeneca Faces $100 Million Impairment After..
1/13/202007:43DJNAstraZeneca, Merck Get FDA Priority Review for Lynparza in..
1/13/202003:27ALNCTOP NEWS: Astra Ends Epanova Trial; Lynparza Gets US..
1/13/202002:37DJNAstraZeneca to Discontinue Epanova Trial Following..
1/13/202002:01UKREGAstraZeneca PLC Lynparza granted FDA Priority Review for..
1/13/202002:00UKREGAstraZeneca PLC Update on Epanova Phase III STRENGTH trial
1/06/202007:51DJNFDA to Review Extending Uses for AstraZeneca-Controlled Drug
1/06/202005:44ALNCIN THE KNOW: JPMorgan Positive On AstraZeneca's Prospects;..
1/06/202003:04ALNCTOP NEWS: Astra's Lokelma Approved In China, Farxiga Gets..
1/06/202002:01UKREGAstraZeneca PLC Farxiga granted FDA heart failure Priority..
1/06/202002:00UKREGAstraZeneca PLC Lokelma approved in China for hyperkalaemia
1/02/202010:00UKREGAstraZeneca PLC Total Voting Rights
12/30/201907:49DJNAstraZeneca, Merck Get FDA OK for Lynparza in Pancreatic..
12/30/201904:49ALNCIN THE KNOW: Shore Keeps AstraZeneca Targets After Lynparza..
12/30/201902:54ALNCTOP NEWS: Astra, Merck & Co's Lynparza Approved For Cancer..
12/30/201902:42DJNFDA Approves AstraZeneca's Lynparza for Pancreatic Cancer
12/30/201902:00UKREGAstraZeneca PLC US FDA approved Lynparza for pancreatic..
12/23/201903:12ALNCAstraZeneca's Triple-Combination Therapy Approved In China
12/23/201902:00UKREGAstraZeneca PLC Enhertu (trastuzumab deruxtecan) approved in..
12/21/201906:51ALNCUS FDA Approves AstraZeneca Breast Cancer Treatment Enhertu
12/20/201903:09ALNCAstraZeneca Sells Two Cancer Drug Rights For Up To USD198..
12/20/201902:41DJNAstraZeneca Sells Rights to Two Cancer Medicines for $181..
12/20/201902:00UKREGAstraZeneca PLC AstraZeneca divests rights to Arimidex and..
12/17/201915:05DJNAstraZeneca, Merck Say FDA Panel Recommends Lynparza in..
12/17/201913:36ALNCAstraZeneca Says Lynparza Recommended By FDA For Pancreatic..
12/17/201913:06UKREGAstraZeneca PLC FDA panel backs Lynparza use for pancreatic..
12/16/201902:57ALNCAstraZeneca Divests Seroquel, Seroquel XR Rights In Europe..
12/16/201902:00UKREGAstraZeneca PLC Seroquel rights agreement complete: Europe,..
12/12/201903:35ALNCAstraZeneca Receives Marketing Authorization In China For..
12/12/201902:53DJNAstraZeneca: Imfinzi Approved in China for Stage III..
12/12/201902:01UKREGAstraZeneca PLC Imfinzi approved in China for Stage III..
12/11/201908:41ALNCAstra's Trastuzumab Deruxtecan Achieves Tumour Response Rate..
12/11/201908:00UKREGAstraZeneca PLC Trastuzumab deruxtecan achieves ORR of 60.9%
12/09/201901:51ALNCPositive Results From AstraZeneca Trial Of Calquence Drug In..
12/05/201903:31ALNCAstraZeneca, Merck Get Marketing Authorization In China For..
12/05/201902:01UKREGAstraZeneca PLC Lynparza approved in China for 1L BRCAm..
12/03/201903:47ALNCAstraZeneca Divests North American Seroquel and Seroquel XR..
12/03/201902:47DJNAstraZeneca Sells Seroquel Rights to Cheplapharm
12/03/201902:00UKREGAstraZeneca PLC AstraZeneca divests Seroquel rights: US and..
12/02/201910:00UKREGAstraZeneca PLC Block listing Interim Review
11/29/201903:13ALNCTOP NEWS: AstraZeneca's Imfinzi Gains Priority Review From..
11/29/201902:43DJNAstraZeneca Gets US License for Imfinzi Lung-Cancer Drug
11/29/201902:00UKREGAstraZeneca PLC Imfinzi granted FDA Priority Review for SCLC
11/22/201905:40ALNCIN THE KNOW: Calquence Permit "Significant Milestone" For..
11/21/201913:40ALNCUS Approves AstraZeneca's Calquence In Chronic Lymphocytic..
See more news about this stock »
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200121 03:06:16